1. Björklund J, Stattin P, Rönmark E, Aly M, Akre O. 90-day cause-specific mortality after radical prostatectomy. Nationwide population-based study. BJU Int. 2021 Jun. Sammanfattning 
  2. Orrason AW, Garmo H, Styrke J, Dickman PW, Stattin P. Comparison of Relative Survival and Cause-specific Survival in Men with Prostate Cancer According to Age and Risk Category. Nationwide, Population-based Study. Am J Epidemiol. 2021 May. Sammanfattning
  3. Gedeborg R, Sund M, Lambe M, Plym A, Fredriksson I, Syrjä J, Holmberg L, Robinson D, Stattin P, Garmo H. An Aggregated Comorbidity Measure Based on History of Filled Drug Prescriptions: Development and Evaluation in Two Separate Cohorts. Epidemiology. 2021 Jul. Sammanfattning
  4. Lundström KJ, Garmo H, Gedeborg R, Stattin P, Styrke J. Short-term ciprofloxacin prophylaxis for prostate biopsy and risk of aortic aneurysm. Nationwide, population-based cohort study. Scand J Urol. 2021 Jun. Sammanfattning
  5. Fallara G, Sandin F, Styrke J, Carlsson S, Lissbrant IF, Ahlgren J, Bratt O, Lambe M, Stattin P. Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic. Scand J Urol. 2021 Jun. Sammanfattning
  6. George G, Vikman H, Gedeborg R, Lissbrant IF, Garmo H, Styrke J, Van Hemelrijck M, Stattin P. Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden. Acta Oncol. 2021 Feb. Sammanfattning